Strategic Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$274K Sell
705
-44
-6% -$17.1K 0.05% 149
2025
Q1
$326K Sell
749
-184
-20% -$80K 0.06% 157
2024
Q4
$344K Sell
933
-67
-7% -$24.7K 0.06% 157
2024
Q3
$520K Sell
1,000
-1,000
-50% -$520K 0.1% 139
2024
Q2
$1.08M Hold
2,000
0.21% 93
2024
Q1
$1.04M Buy
2,000
+1
+0.1% +$518 0.2% 97
2023
Q4
$943K Buy
1,999
+1
+0.1% +$472 0.18% 103
2023
Q3
$870K Buy
1,998
+66
+3% +$28.7K 0.17% 109
2023
Q2
$858K Sell
1,932
-100
-5% -$44.4K 0.16% 114
2023
Q1
$934K Buy
2,032
+51
+3% +$23.4K 0.19% 102
2022
Q4
$1.02M Sell
1,981
-1
-0.1% -$513 0.23% 92
2022
Q3
$900K Buy
1,982
+10
+0.5% +$4.54K 0.2% 96
2022
Q2
$951K Buy
1,972
+14
+0.7% +$6.75K 0.2% 95
2022
Q1
$961K Buy
1,958
+2
+0.1% +$982 0.17% 106
2021
Q4
$907K Buy
1,956
+1
+0.1% +$464 0.13% 118
2021
Q3
$729K Buy
1,955
+1
+0.1% +$373 0.16% 121
2021
Q2
$746K Buy
1,954
+1
+0.1% +$382 0.19% 99
2021
Q1
$701K Buy
1,953
+1
+0.1% +$359 0.2% 93
2020
Q4
$658K Buy
1,952
+2
+0.1% +$674 0.19% 92
2020
Q3
$555K Buy
1,950
+1
+0.1% +$285 0.19% 95
2020
Q2
$522K Buy
1,949
+349
+22% +$93.5K 0.19% 90
2020
Q1
$395K Buy
1,600
+2
+0.1% +$494 0.17% 97
2019
Q4
$483K Buy
1,598
+2
+0.1% +$605 0.17% 111
2019
Q3
$383K Sell
1,596
-22
-1% -$5.28K 0.14% 125
2019
Q2
$456K Sell
1,618
-1,901
-54% -$536K 0.17% 106
2019
Q1
$1.01M Sell
3,519
-144
-4% -$41.3K 0.39% 65
2018
Q4
$962K Buy
3,663
+158
+5% +$41.5K 0.42% 61
2018
Q3
$960K Buy
3,505
+8
+0.2% +$2.19K 0.35% 65
2018
Q2
$832K Buy
3,497
+81
+2% +$19.3K 0.33% 66
2018
Q1
$751K Buy
3,416
+454
+15% +$99.8K 0.31% 73
2017
Q4
$666K Sell
2,962
-97
-3% -$21.8K 0.27% 86
2017
Q3
$581K Buy
3,059
+602
+25% +$114K 0.25% 90
2017
Q2
$462K Sell
2,457
-971
-28% -$183K 0.21% 100
2017
Q1
$567K Buy
+3,428
New +$567K 0.27% 84